Lyell Immunopharma Inc (LYEL)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 49.6M | 1.35M | 596k | 317k | 654k | 1.09M | 989k | 764k |
| Operating Income | -14.78M | -62.56M | -65.91M | -59.04M | -59.51M | -55.58M | -51.53M | -50.51M |
| Pre Tax Income | -8.4M | -66.96M | -63.89M | -50.85M | -52.93M | -60.67M | -45.81M | -44.58M |
| Net Income | -8.4M | -66.96M | -63.89M | -50.85M | -52.93M | -60.67M | -45.81M | -44.58M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -12.9M | -61.46M | -66.23M | -57.46M | -60.01M | -54.49M | -52.17M | -50.55M |
| EBITDA | -9.74M | -57.53M | -60.84M | -53.94M | -54.45M | -50.55M | -46.63M | -45.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 657k | 17.19M | 12.97M | 89.44M | 2.92M |
| Operating Income | -102.09M | -211.94M | -214.78M | -187.06M | -247.01M |
| Pre Tax Income | -129.38M | -204.47M | -250.22M | -183.12M | -234.63M |
| Net Income | -129.38M | -204.47M | -250.22M | -183.12M | -234.63M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -11.571 | -13.132 | -1.031 | -0.734 | -0.932 |
| EBIT | -137.5M | -210.41M | -214.94M | -185.17M | -245.16M |
| EBITDA | -100.83M | -207.64M | -201.28M | -169.04M | -226.76M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
